NYKD · Nykode Therapeutics ASA
3.52
NOKUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
NOK1.36B
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 07/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 200
- HALO All
- HALO Consensus Value
- HALO Earnings Momentum
- HALO Momentum
- HALO Price Momentum
- HALO Small
- Hammer Bearish (Realtime)
Key Fundamentals
EPS 3 yr Growth
-74.60%
EBITDA Margin
N/A
Operating Cashflow
-$26m
Free Cash Flow Return
-21.50%
ROIC
-10.10%
Interest Coverage
-214.50
Quick Ratio
10.00
Performance
52 weeks range
Low 1.59 - 5.2
Trade Value (12mth)
US$107,120.00
1 week
-11.01%
1 month
-15.14%
YTD
47.5%
1 year
107.59%
All time high
93.00
Additional Data
Shares Outstanding (Fully Diluted)
327m
HALO Sector
Healthcare
Next Company Report Date
24-Feb-27
Next Ex Dividend Date
27-May-25
Next Dividend Pay Date
12-Jun-25
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Very Weak
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Strong
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Jan Haudemann-Andersen | Individual |
| Rasmussen Family | Individual |
| Andenaes Family | Individual |
| NORDA ASA | Public Company |
| Joh Johannson Eiendom AS | Private Company |
